Mascoma Project Technology. Except as provided in Sections 3.1 and 3.2, Mascoma will own any and all new technology and intellectual property invented, discovered, reduced to practice. created, or developed under this Agreement that is primarily related to (i) CBP organisms and enzymes and recombinant DNA technology, and (ii) the research, development and commercialization of any such organisms, enzymes or recombinant DNA technology and related know-how for the bio-conversion, bio-mass pretreatment. and advanced biological processing of cellulosic feedstocks or corn into ethanol and related products, including processing that produces DG. HPDG, lignin or other materials as a by-product (the “Mascoma Project Technology”), whether developed by ICM. Mascoma. or jointly by the Parties. Mascoma will promptly disclose any Mascoma Project Technology to ICM. Mascoma will control, in its sole discretion, the preparation, filing, prosecution, maintenance and enforcement of all rights in such intellectual property, including but not limited to patents. ICM does hereby assign to Mascoma any and all rights it has or may have in such intellectual property and inventions and agrees to sign any written assignments as may be reasonably requested by Mascoma to confirm and/or effectuate such assignment. Further. ICM hereby agrees to cooperate with Mascoma and provide all reasonable assistance requested by Mascoma in connection with any patent or other applications Mascoma may choose to file or in connection with any action to enforce Mascoma’s intellectual property rights.
Appears in 2 contracts
Sources: Collaboration Agreement (Mascoma Corp), Collaboration Agreement (Mascoma Corp)